论文部分内容阅读
体外反搏辅助治疗淤胆型病毒性肝炎是一种新的尝试,近年来,我们将本疗法与激素治疗同类病人的疗效作了比较,疗效满意,现报道如下。 资料和方法 淤胆型病毒性肝炎诊断依据1990年全国病毒性肝炎上海会议的标准,对病人采用双盲法随机进行体外反搏治疗(治疗组)及激素治疗(对照组)。治疗组中,男8例,女2例,年龄16～48岁,平均37.4岁,其中急性淤胆型肝炎3例,慢性淤胆型肝炎7例;对照组中,男8例,女2例,年龄17～64岁,平均41.1岁,急性淤胆型肝炎7例,慢性淤胆型肝炎3例。 治疗方法:治疗组用佛山分析仪器厂EECP-MCI型体外反搏装置治疗,每天1次,每次1小时,每12天为1疗程,一般治疗2～3个疗程;川芎嗪注射液80mg加654—2注射液10mg稀释后静滴,每天1次,疗程
External counterpulsation auxiliary treatment of cholestatic hepatitis is a new attempt, in recent years, we will be therapies and hormone therapy in patients with similar efficacy were compared with satisfactory results, are reported below. Materials and Methods The diagnosis of cholestatic hepatitis was based on the standard of Shanghai National Conference on Viral Hepatitis in 1990. The patients were treated with external counterpulsation (treatment group) and hormone therapy (control group) by double-blind method. Treatment group, 8 males and 2 females, aged 16 to 48 years, an average of 37.4 years, of which 3 cases of acute cholestatic hepatitis, chronic cholestatic hepatitis in 7 cases; control group, 8 males and 2 females , Aged 17 to 64 years, mean 41.1 years, 7 cases of acute cholestatic hepatitis, 3 cases of chronic cholestatic hepatitis. Treatment: The treatment group with Foshan Instrument Factory EECP-MCI EECP treatment, 1 times a day, every 1 hour, every 12 days for a course of treatment, the general treatment of 2 to 3 courses of treatment; Ligustrazine injection 80mg plus 654-2 injection intravenous infusion of 10mg diluted 1 day, course of treatment